3829 related articles for article (PubMed ID: 7520026)
1. Expression of the co-stimulatory molecule B7 on melanoma cells.
Hersey P; Si Z; Smith MJ; Thomas WD
Int J Cancer; 1994 Aug; 58(4):527-32. PubMed ID: 7520026
[TBL] [Abstract][Full Text] [Related]
2. In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated anti-tumor immunity.
Denfeld RW; Dietrich A; Wuttig C; Tanczos E; Weiss JM; Vanscheidt W; Schöpf E; Simon JC
Int J Cancer; 1995 Jul; 62(3):259-65. PubMed ID: 7543078
[TBL] [Abstract][Full Text] [Related]
3. T cell activation by antigens on human melanoma cells--co-stimulation by B7-1 is neither sufficient nor necessary to stimulate IL-2 secretion by melanoma-specific T cell clones in vitro.
Viret C; Gervois N; Guilloux Y; Le Dréan E; Diez E; Jotereau F
Int Immunol; 1995 Oct; 7(10):1535-43. PubMed ID: 8562498
[TBL] [Abstract][Full Text] [Related]
4. Expression of programmed death 1 ligands by murine T cells and APC.
Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
[TBL] [Abstract][Full Text] [Related]
5. Restoration of alloreactivity of melanoma by transduction with B7.1.
Brady MS; Lee F; Eckels DD; Ree SY; Latouche JB; Lee JS
J Immunother; 2000; 23(3):353-61. PubMed ID: 10838664
[TBL] [Abstract][Full Text] [Related]
6. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
[TBL] [Abstract][Full Text] [Related]
7. Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppression by interleukin 10.
Dummer R; Yue FY; Pavlovic J; Geertsen R; Döhring C; Moelling K; Burg G
Br J Cancer; 1998 May; 77(9):1413-9. PubMed ID: 9652756
[TBL] [Abstract][Full Text] [Related]
8. Expression of B7 costimulatory molecule in cultured human epidermal Langerhans cells is regulated at the mRNA level.
Girolomoni G; Zambruno G; Manfredini R; Zacchi V; Ferrari S; Cossarizza A; Giannetti A
J Invest Dermatol; 1994 Jul; 103(1):54-9. PubMed ID: 7517982
[TBL] [Abstract][Full Text] [Related]
9. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens.
Yi-qun Z; Joost van Neerven RJ; Kasran A; de Boer M; Ceuppens JL
Int Immunol; 1996 Jan; 8(1):37-44. PubMed ID: 8671587
[TBL] [Abstract][Full Text] [Related]
10. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10 inhibits the immune stimulatory potential of melanoma cells retrovirally transduced with human B7.1 or B7.2.
Geertsen R; Yue FY; Pavlovic J; Laine E; Dummer R
Adv Exp Med Biol; 1998; 451():179-88. PubMed ID: 10026870
[No Abstract] [Full Text] [Related]
12. Expression of the co-stimulatory molecule CD40 on melanoma cells.
Thomas WD; Smith MJ; Si Z; Hersey P
Int J Cancer; 1996 Dec; 68(6):795-801. PubMed ID: 8980186
[TBL] [Abstract][Full Text] [Related]
13. FcR cross-linking on monocytes results in impaired T cell stimulatory capacity.
Barcy S; Wettendorff M; Leo O; Urbain J; Kruger M; Ceuppens JL; de Boer M
Int Immunol; 1995 Feb; 7(2):179-89. PubMed ID: 7537534
[TBL] [Abstract][Full Text] [Related]
14. T cells are the main cell type expressing B7-1 and B7-2 in the central nervous system during acute, relapsing and chronic experimental autoimmune encephalomyelitis.
Cross AH; Lyons JA; San M; Keeling RM; Ku G; Racke MK
Eur J Immunol; 1999 Oct; 29(10):3140-7. PubMed ID: 10540325
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating T lymphocytes from renal-cell carcinoma express B7-1 (CD80): T-cell expansion by T-T cell co-stimulation.
Thurnher M; Radmayr C; Hobisch A; Böck G; Romani N; Bartsch G; Klocker H
Int J Cancer; 1995 Sep; 62(5):559-64. PubMed ID: 7545143
[TBL] [Abstract][Full Text] [Related]
16. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production.
Soos JM; Ashley TA; Morrow J; Patarroyo JC; Szente BE; Zamvil SS
Int Immunol; 1999 Jul; 11(7):1169-79. PubMed ID: 10383950
[TBL] [Abstract][Full Text] [Related]
18. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.
Tan P; Anasetti C; Hansen JA; Melrose J; Brunvand M; Bradshaw J; Ledbetter JA; Linsley PS
J Exp Med; 1993 Jan; 177(1):165-73. PubMed ID: 7678111
[TBL] [Abstract][Full Text] [Related]
19. Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma.
Tatsumi T; Takehara T; Katayama K; Mochizuki K; Yamamoto M; Kanto T; Sasaki Y; Kasahara A; Hayashi N
Hepatology; 1997 May; 25(5):1108-14. PubMed ID: 9141426
[TBL] [Abstract][Full Text] [Related]
20. The role of B7-CD28 co-stimulation in tumor rejection.
Yu X; Abe R; Hodes RJ
Int Immunol; 1998 Jun; 10(6):791-7. PubMed ID: 9678760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
